GL
₹2,515.10
+17.10(+0.68%)
GLAXO₹2,515.10+0.68%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsGLAXO valuation summary
GlaxoSmithKline Pharmaceuticals Limited trades at 41.1 times trailing earnings. Return on equity is 43.3% and return on capital employed is 61.3%. The dividend yield is 2.22%.
| P/E | 41.1 |
|---|---|
| ROE | 43.3% |
| ROCE | 61.3% |
| Dividend yield | 2.22% |